Merck & Co., Inc. Other Non-Current Assets
Merck & Co., Inc. (MRK) had Other Non-Current Assets of $19.60 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-07
- 2026-06-30: Other Assets, Noncurrent $19.60B.
- 2026-03-31: Other Assets, Noncurrent $19.81B.
- 2025-12-31: Other Assets, Noncurrent $18.82B.
- 2025-09-30: Other Assets, Noncurrent $18.33B.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $19.60B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $19.81B 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $18.82B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $18.33B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $17.66B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $16.77B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $16.04B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $14.44B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $12.70B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $12.33B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $12.00B 10-K · filed 2025-02-25 | |
| 2023-09-30 | $10.56B 10-Q · filed 2023-11-03 | |
| 2022-12-31 | $9.53B 10-K · filed 2024-02-26 | |
| 2011-03-31 | $5.81B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $5.63B 10-Q · filed 2011-05-09 | |
| 2010-09-30 | $5.40B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $5.03B 10-Q · filed 2010-08-06 | |
| 2010-03-31 | $5.53B 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $5.38B 10-K · filed 2011-02-28 | $5.38B 10-K · filed 2010-03-01 |
| 2009-09-30 | $1.60B 10-Q · filed 2009-10-29 | |
| 2009-06-30 | $1.25B 10-Q · filed 2009-07-24 | |
| 2008-12-31 | $7.63B 10-K · filed 2010-03-01 | $1.38B 10-Q · filed 2009-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |